About
Justin R. Fallon is a Brown University neuroscientist and professor of psychiatry and human behavior whose work spans synapse biology, stem cell regulation, and neurological disease. He is a scientific founder of Bolden Therapeutics and chairs its Scientific Advisory Board, where the company is developing neurogenesis-promoting therapeutics for CNS disease. Bolden’s profile also notes that he previously founded Tivorsan Pharmaceuticals around a recombinant protein therapeutic for Duchenne muscular dystrophy.
Areas of interest
neuroscienceneurogenesisAlzheimer's diseaseneurodegenerative diseaseCNS therapeuticsantisense oligonucleotidesadult neural stem cellspsychiatryDuchenne muscular dystrophyALSFragile X syndrometranslational biotech